Novel antibody may be key to better lung cancer treatment
Researchers develop synthetic antibody that, when combined with common lung cancer drug, prevents relapse of adenocarcinoma tumors in mouse models.
Researchers develop synthetic antibody that, when combined with common lung cancer drug, prevents relapse of adenocarcinoma tumors in mouse models.
In tests on mice, they were able to block the switch that drives abnormal cell growth, so that tumors shrank permanently.
Body Vision Medical offers real-time navigation platform for early-stage lung cancer diagnostics and treatment.
Israel’s Savicell says its test measures the metabolic ‘signatures’ of immune cells circulating in the blood in response to disease.
Israeli researchers formulate drug cocktail that shows promise in mice models for stopping resistance to kinase inhibitors.
Nucleix has received European Union approval to market Bladder EpiCheck test for cancer follow-up. A blood screening for lung cancer is in the works.
New Israeli approach stops lung cancer cells from developing resistance to chemotherapy in mice.
TTFields therapy, developed by an Israeli scientist, delivers low-intensity alternating electric fields via a scalp device to inhibit cancer cells.
Israeli professor’s revolutionary disease-detection device is on the road to changing how early, and how easily, lung cancer is diagnosed.
Joint venture promises early stage, non-invasive screening for the early diagnosis of lung cancer.